5mg · lyophilized · single vial
4.8(1,261 researcher reviews)GLP-1 receptor agonist. Category benchmark.
For research and educational use only. Not for human consumption. Consult a licensed provider before use.
Semaglutide is a long-acting GLP-1 receptor agonist with 94% homology to native GLP-1, engineered for weekly subcutaneous dosing. The STEP trial program demonstrated ~15% mean body-weight reduction — the category benchmark before tirzepatide.
Every KINETYX vial is filled in a controlled cleanroom and sealed with tamper-evident packaging. Batch documentation includes identity confirmation, HPLC purity analysis and concentration verification.
Curated from public preclinical literature. All content is educational.
Semaglutide is a long-acting GLP-1 receptor agonist with 94% homology to native human GLP-1. Chemical modifications (fatty-acid side-chain, amino-acid substitutions) extend its half-life to ~1 week, enabling once-weekly dosing.
The STEP clinical program established the category benchmark for pharmacological weight management: ~15% mean body-weight reduction over 68 weeks in a non-diabetic cohort.
Semaglutide activates the GLP-1 receptor in pancreatic β-cells, potentiating glucose-dependent insulin release.
It also acts centrally in the hypothalamus to reduce appetite and food-reward signaling, and peripherally to slow gastric emptying.
The combined effect: better glucose control, reduced caloric intake, and progressive weight loss.
• ~15% mean body-weight reduction (STEP trials)
• Strong appetite and craving suppression
• Improved HbA1c and cardiovascular endpoints
• Well-defined weekly titration schedule
Standard titration: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly subcutaneously, stepping up every 4 weeks.
1 vial = 5 mg.
Nausea (early cycle)
Constipation
Sulfur-flavored eructation
Gallbladder events at high doses
For in-vitro research use only. Not for human or veterinary consumption.
Enter the bacteriostatic water volume you'll add and the target dose. We'll compute the units on a standard U-100 insulin syringe.
Reference only. Assumes U-100 syringe (100 units = 1 mL). Not medical advice.
Standard titration: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly subcutaneously, stepping up every 4 weeks.
1 vial = 5 mg.
Refrigerate reconstituted vial at 2–8°C. Use within 30 days. Lyophilized vials stable ≥12 months at −20°C.
Yes. Every batch of Semaglutide ships with an HPLC purity report and identity confirmation from an independent lab. Batch numbers are searchable in our Lab Results portal.
Ambient, insulated mailer, discreet plain packaging. Includes BAC water + 12 syringes. Domestic delivery in 24–48h.
Currently US only for research supply. International researcher accounts require verification.
Lyophilized vials remain stable for 12+ months at −20°C. Once reconstituted, refrigerate at 2–8°C and use within 30 days.
Orders placed by 2pm ET ship same day.
Overnight or 2-day, tracked, ambient shipping.
Orders over $150 ship free within the US.
Unopened vials returnable within 14 days. Batch-verified refunds always honored.
Great communication from the team when I asked about batch documentation. Would order again.
Purity is the reason I keep coming back. Third-party HPLC on file is a huge trust signal.
Great communication from the team when I asked about batch documentation. Would order again.
Purity is the reason I keep coming back. Third-party HPLC on file is a huge trust signal.